When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...

New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, ...

The new vaccine, GlaxoSmithKline’s Shingrix, is more than 90% effective in preventing shingles – and that, of course, is its goal. But this research suggests another unexpected advantage. The study ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...

Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...

The predictability of winners contributed to the show’s overall dryness. “The Bear,” which received a record-breaking 23 ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...